(Q39937037)
Statements
A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia (English)
David L Porter
Edward A Stadtmauer
Noelle V Frey
Elizabeth O Hexner
Alison W Loren
Selina M Luger
Sunita D Nasta
Donald E Tsai
Alexander E Perl
Margaret T Kasner
Stephen J Schuster
Steven C Goldstein
Jamil K Dierov
Cezary R Swider
Alan M Gewirtz
Martin Carroll
20 October 2009